Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine

Ann Hematol. 2024 Feb;103(2):671-672. doi: 10.1007/s00277-023-05529-3. Epub 2023 Nov 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Azacitidine / therapeutic use
  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
  • Humans
  • Leukemia, Myeloid, Acute* / complications
  • Leukemia, Myeloid, Acute* / diagnosis
  • Leukemia, Myeloid, Acute* / drug therapy
  • Neoplasms, Second Primary* / diagnosis
  • Neoplasms, Second Primary* / drug therapy
  • Sarcoma, Myeloid* / complications
  • Sarcoma, Myeloid* / diagnosis
  • Sarcoma, Myeloid* / drug therapy
  • Sulfonamides*
  • Urinary Bladder

Substances

  • venetoclax
  • Azacitidine
  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides